


Ask a doctor about a prescription for NORMOSEPT 10 mg/ml CUTANEOUS SPRAY SOLUTION
Package Leaflet: Information for the Patient
Normosept 10 mg/ml Cutaneous Spray Solution
chlorhexidine digluconate
Read the entire package leaflet carefullybefore starting to use thismedication, as it contains important informationfor you.
Follow the administration instructions for the medication contained in this package leaflet or as indicated by your doctor, pharmacist, or nurse.
Package Leaflet Contents
Normosept is a cutaneous antiseptic whose active ingredient is chlorhexidine digluconate. Chlorhexidine is an antiseptic applied to the skin.
Normosept is indicated as an antiseptic for small superficial wounds such as minor burns, scratches, cuts, and abrasions in adults, adolescents, children, and babies from 2 months of age or older.
Do not use Normosept:
Warnings and Precautions
Consult your doctor or pharmacist before starting to use Normosept.
Children
Using Normosept withother medications
Pregnancy and Breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.
There are no known risks associated with the use of Normosept during pregnancy or breastfeeding. It is unknown whether chlorhexidine digluconate or any of its metabolites are excreted in breast milk. No effects are expected during pregnancy, in newborns, or in breastfed infants, as systemic exposure to chlorhexidine is negligible. Normosept can be used during pregnancy or breastfeeding. Breastfeeding women should avoid using it on their breasts.
Driving and Using Machines
The influence of this medication on the ability to drive and use machines is nil or insignificant.
Follow the administration instructions for the medication contained in this package leaflet or as indicated by your doctor or pharmacist. If in doubt, ask your doctor or pharmacist.
This medication should be used on your skin.
The recommended dose is the amount of product sufficient to cover the entire surface of the wound 1 or 2 times a day, until the first signs of healing appear.
The duration of treatment depends on the type and course of the wound, and according to experience, it is approximately 1 to 2 weeks.
You should consult a doctor if the wound worsens or does not improve within 2 days after treatment.
The spray is ready for use. It is recommended to clean and dry the wound before applying this medication. Spray Normosept directly onto the affected area, at a distance of approximately 10 cm from your skin. You can also spray the medication onto a gauze and clean the damaged skin area. After application, let it act and dry.
Once the medication is applied, the antimicrobial effect is achieved in 1 minute.
If you use more Normosept than you should
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested.
Like all medications, Normosept can cause side effects, although not everyone will experience them.
Stop using Normosept and inform your doctor immediately if you have a severe allergic reaction. The frequency of this side effect is unknown (cannot be estimated from available data). If you notice any of the following, contact your doctor immediately:
These may be signs of an allergic reaction.
Other possible side effects, for which the frequency is unknown:
Unknown frequency:
Reporting Side Effects
If you experience any type of side effect, consult your doctor, pharmacist, or nurse, even if it is a possible side effect not listed in this package leaflet. You can also report them directly through the Spanish Medication Surveillance System for Human Use: www.notificaRAM.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of sight and reach of children.
No special storage conditions are required.
Do not use this medication after the expiration date shown on the box after CAD. The expiration date is the last day of the month indicated.
Medications should not be disposed of through wastewater or household waste. Deposit the packaging and medications you no longer need at the SIGRE Point in the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. This will help protect the environment.
Composition of Normosept
Appearance of the Product and Package Contents
Normosept is a clear and colorless solution.
It is presented in a polyethylene terephthalate (PET) bottle, equipped with a spray valve, containing 25 ml.
Marketing Authorization Holder and Manufacturer
LABORATORIOS NORMON, S.A.
Ronda de Valdecarrizo, 6 – 28760 Tres Cantos – Madrid (Spain)
Date of the Last Revision of this Package Leaflet:August 2025
Detailed information about this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for NORMOSEPT 10 mg/ml CUTANEOUS SPRAY SOLUTION – subject to medical assessment and local rules.